Dopamine D<sub>3</sub>/D<sub>2</sub> Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders-Reference-Cited by-同舟云学术

Dopamine D₃/D₂ Receptor Ligands Based on Cariprazine for the Treatment of Psychostimulant Use Disorders That May Be Dual Diagnosed with Affective Disorders

Published:2023-01-20 Issue:3 Volume:66 Page:1809-1834
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Gogarnoiu Emma S.¹^ORCID,Vogt Caleb D.¹,Sanchez Julie²³,Bonifazi Alessandro¹^ORCID,Saab Elizabeth¹,Shaik Anver Basha¹,Soler-Cedeño Omar¹,Bi Guo-Hua¹,Klein Benjamin¹,Xi Zheng-Xiong¹,Lane J. Robert²³^ORCID,Newman Amy Hauck¹^ORCID

Affiliation:

1. Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse─Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States

2. Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, United Kingdom

3. Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Midlands NG2 7AG, United Kingdom

Funder

National Institute on Drug Abuse

NIDA-IRP Medications Development Program

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01624

Reference68 articles.

1. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis

2. Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?

3. A Review of Treatment Options for Co-Occurring Methamphetamine Use Disorders and Depression

4. Treatment of substance use disorders with co-occurring severe mental health disorders

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands;Medicinal Research Reviews;2024-05-29

2. Substance Addiction Rehabilitation Drugs;Pharmaceuticals;2024-05-10

3. Brexpiprazole in patients with schizophrenia with or without substance use disorder: an observational study;Frontiers in Psychiatry;2023-12-04